GlassScriptPhysician profile
Amy M Brown
NPI 1770712275
$2,721.16
in general payments reported to CMS, 2019-2025
26 companies · $386 in 2025
The $386 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $534 · 2022: $525 · 2023: $760 · 2024: $518 · 2025: $386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,663.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,663.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $588.68 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $423.72 | 2021-2025 | Lifevest |
| Edwards Lifesciences Corporation | $265.75 | 2022-2025 | Sapien 3 Ultra Resilia |
| Abiomed | $245.79 | 2023-2024 | Impella |
| Merck Sharp & Dohme LLC | $173.69 | 2022-2025 | Verquvo, Belsomra |
| E.R. Squibb & Sons, L.L.C. | $165.78 | 2022-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $111.64 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $96.62 | 2021-2022 | |
| Amarin Pharma, INC. | $70.48 | 2021 | |
| Amgen INC. | $64.61 | 2021-2023 | Repatha, Otezla |
| Janssen Pharmaceuticals, INC | $61.23 | 2022-2024 | Xarelto |
| Philips North America LLC | $60.36 | 2023-2025 | Extended Holter, (Ck7) Extended Holter, (Ck4) Mcot |
| Abbvie INC. | $52.19 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $47.58 | 2023 | |
| Abbott Laboratories | $43.86 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $41.66 | 2023 | |
| Mylan Specialty L.P. | $40.40 | 2023 | Yupelri |
| Biosense Webster, INC. | $29.37 | 2024 | Carto 3 |
| Pfizer INC. | $27.22 | 2023 | |
| Medtronic, INC. | $26.92 | 2023-2024 | Cobalt Dr Mri Surescan |
| Sanofi-Aventis U.S. LLC | $17.83 | 2022 | |
| Medline Industries LP | $15.00 | 2025 | |
| Glaxosmithkline, LLC. | $13.95 | 2021 | |
| Lilly USA, LLC | $13.93 | 2023 | Trulicity, Mounjaro |
| Exact Sciences Corporation | $12.85 | 2023 | Cologuard Collection Kit |
| Organon LLC | $10.05 | 2023 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.